MicaliF.: La calcolosi urinaria. Ed. Wellcome, 1979.
3.
ChateleinC., MathienH., WeisgerberG.: Les lithiases caldques de l'enfant. Séminaires d'Uronéphrologie, Masson éd., Paris1978.
4.
MalekR. S.: Renal lithiasis: a practical approach. J. Urol., 118; 893 (1977).
5.
KoffS. A., LapidesJ.: Altered bladder function in staghorn calculus disease. J. Urol., 117; 577 (1977).
6.
BruézièreJ., LafargueG., GalletJ. P.: Les coagulums uroprotidiques chez l'enfant: à propos de 6 observations. J. d'Urol., 74; 91 (1968).
7.
TacciuoliM., LottiT., MianoL., LaurentiC.: La calcolosi urinaria nell'infanzia. Relaz. 46° Congr. Soc. It. Urol., Genova 1973.
8.
ElliotJ. S., SharpR. F., LewisL.: The solubility of struvite in urine. J. Urol., 81; 366 (1959).
9.
GriffithD. P., MusherD. M., ItinC.: The primary course of infection-induced urinary stones. Invest. Urol., 13; 346 (1976).
10.
BraudeA. I., SieminskiJ.: Role of bacterial urease in experimental pyelonephritis. J. Bacteriol., 80; 171 (1960).
11.
GriffithD. P., GibsonJ. R., ClintonC. W.: Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi. J. Urol., 119; 9 (1978).
12.
NemayN. J., StameyT. A.: Surgical, bacteriological and biochemical management of « infection stones ». J.A.M.A., 215; 1470 (1971).
13.
KassE. H.: An approach to the management of resistant urinary infections. Kidney Intern., 16; 204 (1979).
14.
ChinnR. H., MaskellR., MeadJ. A., PolakA.: Renal stones and urinary infection: a study of antibiotic treatment. Brit. Med. J., 2; 1411 (1976).
15.
ResmikM. J., BoyceW. H.: Dissolution versus surgical treatment of nephrolithiasis. N. Engl. J. Med., 23; 1488 (1979).
16.
DretlerS. P., PfisterR. C., NewhouseJ. H.: Renal stone dissolution via percutaneous nephrostomy. N. Engl. J. Med., 23; 341 (1979).
FishbeinW. N., DalyJ. E.: Urease inhibitors for hepatic coma. II. Comparative efficacy of four lower hydroxamate homologs in vitro and in vivo. Proc. Soc. Exp. Biol. Med., 134; 1083 (1970).
19.
MusherD. M., GriffithD. P., YawnD.: Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. J. Infect. Dis., 131; 177 (1975).
FishbeinW. N., StreeterC. L., PalyJ.: Physiologic disposition of short chain aliphatic hydroxamates in the mouse: II. Absorption, distribution, metabolism and excretion of 1–14C acetohydroxamic acid. J. Pharm. Exp. Ther., 186; 173 (1973).
22.
MolpertE., HoffmannA. F., SummerskillW. H. J.: Synthesis and metabolism of labeled acetohydroxamic acid, an urease inhibitor. Proc. Soc. Exp. Biol. Med., 136; 592 (1971).
23.
FishbeinW. N., DalyJ., StreeterC. L.: Preparation and some properties of stable and Carbon-14 and tritium labeled short-chain aliphatic hydroxamic acid. Anal. Biochem., 28; 13 (1969).
ChaussyC., SchmidtE., JochamaD., BrendelW., ForssmanB.: First clinical experiences with extracorporally induced destruction of kidney stones by shock waves. J. Urol., in press.
27.
AlkenP., HutschenreitterG., GuntlerR., MarbergerM.: Percutaneous stone manipulation. J. Urol., 125; 453 (1981).